Jones Jermaine D, Atchison Jared J, Madera Gabriela, Metz Verena E, Comer Sandra D
Division of Substance Abuse, New York State Psychiatric Institute/College of Physicians and Surgeons of Columbia University, 1051 Riverside Drive, New York, NY 10032, USA.
Translational Research Training Program in Addiction at City College of New York & Sophie Davis School of Biomedical Education, 160 Convent Avenue, New York, NY 10032, USA.
Drug Alcohol Depend. 2015 Aug 1;153:201-6. doi: 10.1016/j.drugalcdep.2015.05.021. Epub 2015 May 27.
Deceptive methods of falsifying urine samples are of concern for anyone who relies on accurate urine toxicology results. A novel method to combat these efforts utilizes polyethylene glycol (PEG) markers administered orally prior to providing a urine sample. By using various PEG combinations to create a tracer capsule of unique composition, each urine sample can be matched to that individual. The goal of this study was to determine the effectiveness of using the PEG marker system among active heroin users screening for research studies.
Upon each screening visit, participants (N=55) were randomized to provide an unobserved urine sample, or the PEG tracer procedure was used. LCMS analysis was used to distinguish the PEG combinations, and allowed us to provide a unique qualitative analysis of patterns of drug use (N=168, total urine specimens).
The unique composition of the tracer capsules was accurately detected in 83.5% of the urine specimens. Analyses of inconsistencies implicated a number of possible attempts at fraudulence (11.4%) and investigator/lab error (5.1%). Among this sample, the concurrent use of multiple classes of psychoactive drugs was more common than not, though concomitant drug use was often underreported.
Urine drug testing should be the minimum standard for obtaining information about drug use as self-report was unreliable even in a situation where there were no perceived adverse consequences for full disclosure. In cases where there are significant pressures for individuals to falsify these data, more protective collection methods such as the PEG marker system should be considered.
对于任何依赖准确尿液毒理学检测结果的人来说,伪造尿液样本的欺骗方法都令人担忧。一种对抗这些行为的新方法是在提供尿液样本之前口服聚乙二醇(PEG)标记物。通过使用各种PEG组合来创建具有独特成分的示踪胶囊,每个尿液样本都可以与个体进行匹配。本研究的目的是确定在为研究筛选的活跃海洛因使用者中使用PEG标记系统的有效性。
在每次筛查就诊时,参与者(N = 55)被随机分配提供一份无人监督的尿液样本,或采用PEG示踪程序。使用液相色谱 - 质谱联用(LCMS)分析来区分PEG组合,并使我们能够对药物使用模式进行独特的定性分析(N = 168,尿液样本总数)。
在83.5%的尿液样本中准确检测到了示踪胶囊的独特成分。对不一致情况的分析表明存在一些可能的欺诈企图(11.4%)和调查人员/实验室错误(5.1%)。在这个样本中,同时使用多种精神活性药物的情况较为常见,尽管药物的同时使用情况往往报告不足。
尿液药物检测应作为获取药物使用信息的最低标准,因为即使在完全披露没有可察觉的不良后果的情况下,自我报告也不可靠。在个人有很大压力伪造这些数据的情况下,应考虑采用更具保护性的采集方法,如PEG标记系统。